Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1

Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has been discussed for its safety and efficacy in cancer treatments. For this reason, we have inquired into its use on triple-negative human breast cancer. Analyzing the biological effects of CBD on MDA-MB-231, we have demonstrated that b...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Aloia, Alessia, Ceriani, Michela, Tisi, Renata, Stucchi, Simone, Sacco, Elena, Costa, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266539/
https://www.ncbi.nlm.nih.gov/pubmed/35806150
http://dx.doi.org/10.3390/ijms23137145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266539/
https://www.ncbi.nlm.nih.gov/pubmed/35806150
http://dx.doi.org/10.3390/ijms23137145

Ejemplares similares